Literature DB >> 19122120

Differential gene expression in central nervous system lymphoma.

James L Rubenstein, Arthur Shen, Tracy T Batchelor, Cigall Kadoch, Patrick Treseler, Marc A Shuman.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19122120      PMCID： PMC2614638          DOI： 10.1182/blood-2008-04-152835

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  7 in total

1.  Gene expression and angiotropism in primary CNS lymphoma.

Authors:  James L Rubenstein; Jane Fridlyand; Arthur Shen; Ken Aldape; David Ginzinger; Tracy Batchelor; Patrick Treseler; Mitchel Berger; Michael McDermott; Michael Prados; Jon Karch; Craig Okada; William Hyun; Seema Parikh; Chris Haqq; Marc Shuman
Journal:  Blood       Date:  2006-01-17       Impact factor: 22.113

2.  BCL2 regulates neural differentiation.

Authors:  K Z Zhang; J A Westberg; E Hölttä; L C Andersson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

3.  Growth-associated proteins and the curious dichotomies of nerve regeneration.

Authors:  J H Skene
Journal:  Cell       Date:  1984-07       Impact factor: 41.582

Review 4.  Bcl-2 gene family in the nervous system.

Authors:  D E Merry; S J Korsmeyer
Journal:  Annu Rev Neurosci       Date:  1997       Impact factor: 12.449

5.  Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cell.

Authors:  M Montesinos-Rongen; A Brunn; S Bentink; K Basso; W K Lim; W Klapper; C Schaller; G Reifenberger; J Rubenstein; O D Wiestler; R Spang; R Dalla-Favera; R Siebert; M Deckert
Journal:  Leukemia       Date:  2007-11-08       Impact factor: 11.528

6.  Pathway analysis of primary central nervous system lymphoma.

Authors:  Han W Tun; David Personett; Karen A Baskerville; David M Menke; Kurt A Jaeckle; Pamela Kreinest; Brandy Edenfield; Abba C Zubair; Brian P O'Neill; Weil R Lai; Peter J Park; Michael McKinney
Journal:  Blood       Date:  2008-01-09       Impact factor: 22.113

7.  Endoglin (CD 105) is expressed on endothelial cells in the primary central nervous system lymphomas and correlates with survival.

Authors:  Yasuo Sugita; Yukari Takase; Daisuke Mori; Osamu Tokunaga; Akihiko Nakashima; Minoru Shigemori
Journal:  J Neurooncol       Date:  2006-11-11       Impact factor: 4.506
  7 in total
  20 in total

Review 1.  Aggressive B-cell lymphomas: a review of new and old entities in the WHO classification.

Authors:  Elaine S Jaffe; Stefania Pittaluga
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2011

Review 2.  Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium.

Authors:  Chi-Chao Chan; James L Rubenstein; Sarah E Coupland; Janet L Davis; J William Harbour; Patrick B Johnston; Nathalie Cassoux; Valerie Touitou; Justine R Smith; Tracy T Batchelor; Jose S Pulido
Journal:  Oncologist       Date:  2011-11-01

3.  Primary central nervous system B cell lymphoma with features intermediate between diffuse large B cell lymphoma and Burkitt lymphoma.

Authors:  Liuyan Jiang; Zhimin Li; Laura E Finn; David A Personnet; Brandy Edenfield; James M Foran; Kurt A Jaeckle; Ronald Reimer; David M Menke; Rhett P Ketterling; Han W Tun
Journal:  Int J Clin Exp Pathol       Date:  2012-01-01

4.  The Role of Lymphocyte to Monocyte Ratio, Microvessel Density and HiGH CD44 Tumor Cell Expression in Non Hodgkin Lymphomas.

Authors:  Jelena Jelicic; Milena Todorovic Balint; Maja Perunicic Jovanovic; Novica Boricic; Marjan Micev; Jelena Stojsic; Darko Antic; Bosko Andjelic; Jelena Bila; Bela Balint; Sonja Pavlovic; Biljana Mihaljevic
Journal:  Pathol Oncol Res       Date:  2016-01-11       Impact factor: 3.201

Review 5.  Biology and treatment of primary central nervous system lymphoma.

Authors:  Alain P Algazi; Cigall Kadoch; James L Rubenstein
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

Review 6.  The histological classification of diffuse large B-cell lymphomas.

Authors:  Yi Xie; Stefania Pittaluga; Elaine S Jaffe
Journal:  Semin Hematol       Date:  2015-01-17       Impact factor: 3.851

7.  T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Presenting as a Primary Central Nervous System Lymphoma.

Authors:  Pooja Advani; Jason Starr; Abhisek Swaika; Liuyan Jiang; Yushi Qiu; Zhimin Li; Han W Tun
Journal:  Rare Tumors       Date:  2015-12-29

8.  Craniotomy and Survival for Primary Central Nervous System Lymphoma.

Authors:  Ali I Rae; Amol Mehta; Michael Cloney; Connor J Kinslow; Tony J C Wang; Govind Bhagat; Peter D Canoll; George J Zanazzi; Michael B Sisti; Sameer A Sheth; E Sander Connolly; Guy M McKhann; Jeffrey N Bruce; Fabio M Iwamoto; Adam M Sonabend
Journal:  Neurosurgery       Date:  2019-04-01       Impact factor: 4.654

9.  Prognostic significance of the aggregative perivascular growth pattern of tumor cells in primary central nervous system diffuse large B-cell lymphoma.

Authors:  Miaoxia He; Changjing Zuo; Jianjun Wang; Jianmin Liu; Binghua Jiao; Jianmin Zheng; Zailong Cai
Journal:  Neuro Oncol       Date:  2013-03-12       Impact factor: 12.300

Review 10.  The histological and biological spectrum of diffuse large B-cell lymphoma in the World Health Organization classification.

Authors:  Madhu P Menon; Stefania Pittaluga; Elaine S Jaffe
Journal:  Cancer J       Date:  2012 Sep-Oct       Impact factor: 3.360
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.